|
Volumn 190, Issue 3, 2009, Pages 248-253
|
What happened: The chemistry side of the incident with EMS contamination in Viracept tablets
|
Author keywords
Analytical method development; Ethyl methane sulfonate; Nelfinavir mesilate; Patient exposure; Stability study; Viracept
|
Indexed keywords
MESYLIC ACID ETHYL ESTER;
MESYLIC ACID METHYL ESTER;
NELFINAVIR;
ARTICLE;
CHEMICAL REACTION;
CONCENTRATION (PARAMETERS);
DERIVATIZATION;
DRUG COATING;
DRUG CONTAMINATION;
DRUG DISTRIBUTION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG IMPURITY;
DRUG MANUFACTURE;
DRUG QUALITY;
DRUG SAFETY;
DRUG SCREENING;
DRUG STABILITY;
DRUG STORAGE;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GENOTOXICITY;
HEALTH HAZARD;
HUMAN;
MASS FRAGMENTOGRAPHY;
PRIORITY JOURNAL;
QUALITY CONTROL;
RECOMMENDED DRUG DOSE;
REFERENCE VALUE;
STORAGE TEMPERATURE;
TABLET FORMULATION;
TEMPERATURE SENSITIVITY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG CONTAMINATION;
ENVIRONMENTAL EXPOSURE;
ETHYL METHANESULFONATE;
GAS CHROMATOGRAPHY-MASS SPECTROMETRY;
HIV PROTEASE INHIBITORS;
HUMANS;
MUTAGENS;
NELFINAVIR;
PRODUCT SURVEILLANCE, POSTMARKETING;
TABLETS;
|
EID: 69549149575
PISSN: 03784274
EISSN: None
Source Type: Journal
DOI: 10.1016/j.toxlet.2009.02.020 Document Type: Article |
Times cited : (39)
|
References (5)
|